Focused on novel, nanotechnology-based therapeutics.
Cerulean Pharma Inc. is a clinical-stage biopharmaceutical company specializing in the design and development of nanopharmaceuticals. Cerulean’s nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance efficacy and tolerability of therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules.
Cerulean is pursuing three key strategies:
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide.
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
Abraxis BioScience is a fully integrated biotechnology company dedicated to delivering progressive therapeutics, such as ABRAXANE, and core technologies that offer patients and medical professionals safer and more effective treatments for cancer and other critical illnesses.
Siemens Healthcare Diagnostics offers a broad portfolio of performance-driven diagnostics solutions that provide more effective ways to assist in the diagnosis, monitoring and management of disease. Our products and services offer the right balance of science, technology and practicality across the healthcare continuum to provide healthcare professionals with the vital information they need to deliver better, more personalized healthcare to patients around the globe.
Inverness Medical Innovations, Inc. is at the forefront of the convergence between medical diagnostic testing and health management. IMA is a major global developer, manufacturer and marketer of advanced, pioneering professional and consumer medical diagnostic products, as well as a leader in specialized health management services including wellness, disease management, oncology and women and children's health.